Fady Ibraham Malik - EVP Research & Development at Cytokinetics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP Research & Development
Stock Symbol
CYTK on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Fady Ibraham Malik - trading volume in the past year for Cytokinetics Inc

Holdings reported by Fady Ibraham Malik for Cytokinetics Inc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 131 K $7.32 M $55.89 Jul 9, 2024 Direct
Non-Qualified Stock Option (Right to Buy) 58.3 K $0 $41.69 Jul 9, 2024 Direct Common Stock
Incentive Stock Option (Right to Buy) 0 $0 $37.63 May 7, 2024 Direct Common Stock

Transactions reported by Fady Ibraham Malik for Cytokinetics Inc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership